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Summary
Background Despite the increasing popularity of activity trackers, little evidence exists that they can improve health 
outcomes. We aimed to investigate whether use of activity trackers, alone or in combination with cash incentives or 
charitable donations, lead to increases in physical activity and improvements in health outcomes.
Methods In this randomised controlled trial, employees from 13 organisations in Singapore were randomly assigned 
(1:1:1:1) with a computer generated assignment schedule to control (no tracker or incentives), Fitbit Zip activity tracker, 
tracker plus charity incentives, or tracker plus cash incentives. Participants had to be English speaking, full-time 
employees, aged 21–65 years, able to walk at least ten steps continuously, and non-pregnant. Incentives were tied to 
weekly steps, and the primary outcome, moderate-to-vigorous physical activity (MVPA) bout min per week, was measured 
via a sealed accelerometer and assessed on an intention-to-treat basis at 6 months (end of intervention) and 12 months 
(after a 6 month post-intervention follow-up period). Other outcome measures included steps, participants meeting 
70 000 steps per week target, and health-related outcomes including weight, blood pressure, and quality-of-life measures. 
This trial is registered at ClinicalTrials.gov, number NCT01855776.
Findings Between June 13, 2013, and Aug 15, 2014, 800 participants were recruited and randomly assigned to the 
control (n=201), Fitbit (n=203), charity (n=199), and cash (n=197) groups. At 6 months, compared with control, the cash 
group logged an additional 29 MVPA bout min per week (95% CI 10–47; p=0·0024) and the charity group an additional 
21 MVPA bout min per week (2–39; p=0·0310); the difference between Fitbit only and control was not significant 
(16 MVPA bout min per week [–2 to 35; p=0·0854]). Increases in MVPA bout min per week in the cash and charity 
groups were not significantly greater than that of the Fitbit group. At 12 months, the Fitbit group logged an additional 
37 MVPA bout min per week (19–56; p=0·0001) and the charity group an additional 32 MVPA bout min per week 
(12–51; p=0·0013) compared with control; the difference between cash and control was not significant (15 MVPA bout 
min per week [–5 to 34; p=0·1363]). A decrease in physical activity of –23 MVPA bout min per week (95% CI 
–42 to –4; p=0·0184) was seen when comparing the cash group with the Fitbit group. There were no improvements in
any health outcomes (weight, blood pressure, etc) at either assessment.
Interpretation The cash incentive was most effective at increasing MVPA bout min per week at 6 months, but this 
effect was not sustained 6 months after the incentives were discontinued. At 12 months, the activity tracker with or 
without charity incentives were effective at stemming the reduction in MVPA bout min per week seen in the control 
group, but we identified no evidence of improvements in health outcomes, either with or without incentives, calling 
into question the value of these devices for health promotion. Although other incentive strategies might generate 
greater increases in step activity and improvements in health outcomes, incentives would probably need to be in place 
long term to avoid any potential decrease in physical activity resulting from discontinuation.
Funding Ministry of Health, Singapore.
Introduction
Non-communicable diseases are fast emerging as the 
major health challenge for the 21st century and are 
responsible for nearly two-thirds of global deaths annually.1 
Physical inactivity is an important risk factor for non-
communicable diseases and has been identified as the 
fourth leading risk factor for global mortality, contributing 
to 9% of deaths annually.2 Inactivity also imposes 
substantial costs to governments, insurers, and employers 
through increased medical expenditures for treating non-
communicable diseases and reductions in productivity.3
Wearable activity trackers have greatly enhanced our 
ability to track and potentially increase physical activity 
levels. The affordability, ease of wear, and aesthetics of 
these devices have increased their popularity. One in ten 
US adults now owns an activity tracker.4 These devices 
are also increasingly being used by employers, insurers, 
and governments to promote physical activity.5,6
On the basis of their systematic review, Bravata and 
colleagues7 suggest that pedometers increase physical 
activity by an average of 26·9% over baseline and generate 
slight improvements in BMI and systolic blood pressure. 
However, in most of the studies reviewed, the step 
differences were measured with a pedometer, which does 
not allow differences in wear time to be disentangled from 
actual increases in activity. Weight loss was not a function 
of increases in daily steps and blood pressure reductions 
were potentially caused by regression to the mean. The 
mean intervention duration was only 18 weeks and results 
were weakest for people who were employed full-time 
compared with people who were not. In a 2013 Cochrane 
review8 on workplace pedometer interventions, Freak-Poli 
and colleagues concluded that insufficient data exist to 
determine the effectiveness of pedometer-based inter-
ventions in the workplace. Moreover, market research data 
reveal that more than 50% of US consumers who 
purchased activity trackers no longer wear them, with a 
third abandoning them within 6 months of purchase.4 
These results call into question the ability of trackers to 
improve population health.
As originally designed, activity trackers provided timely 
feedback to wearers on step activity. For many, this 
feedback had little value once the novelty of the device 
wore off. People who were consistently active or inactive 
quickly learned what their typical daily step count was. 
Consequently, the devices provided little by way of new 
information and so it was not surprising that many 
abandoned them after a few weeks or months. 
Manufacturers are aware of this limitation and now 
couple the devices with social media and other sources of 
information and feedback to increase their value. As 
such, consumers might be less likely to abandon the new 
wearables, which should increase their effectiveness.
Another strategy that could increase the value of activity 
trackers is to couple them with incentives for reaching 
activity goals. Economic theory predicts that incentives, by 
increasing the benefits of physical activity, would generate 
increased physical activity as individuals strive to obtain set 
rewards. Incentives need not involve individual rewards. 
An alternative approach could be to earmark incentives to 
a designated charity, as is commonly done in walkathons.9 
Although we could not find any published reports of 
studies testing this approach, it might promote sustained 
behaviour change while not violating social norms 
(ie, creating a financial transaction in response to activities 
for which this is not typically done),10,11 which might occur 
with the uncommon practice of paying people to exercise. 
Charitable incentives tied to health behaviours are also 
Research in context
Evidence before this study
In preparation for this trial, we began with the systematic review 
of pedometer studies by Bravata and colleagues in 2007. Their 
review suggests that pedometer use increases physical activity 
by an average of 26·9% over baseline, and produces slight 
reductions in BMI and improvements in systolic blood pressure. 
However, the review raised several concerns that question the 
veracity of the results. In most of the studies reviewed, the step 
differences were measured using a pedometer, which does not 
allow for disentangling differences in wear time from actual 
increases in steps. Bravata and colleagues further noted that 
weight loss was not a function of increases in daily steps and 
that blood pressure reductions were potentially caused by 
regression to the mean. Moreover, mean intervention duration 
was only 18 weeks and results were weak for workplace 
interventions. The authors concluded by stating that large 
randomised controlled trials are needed to fully elucidate the 
potential benefits of pedometers. In a 2013 Cochrane review on 
workplace pedometer interventions, Freak-Poli and colleagues 
concluded that insufficient evidence was available to assess 
effectiveness of pedometer-based interventions in the 
workplace. Market research further reveals that roughly a third 
of people who purchase activity trackers abandon them within 
6 months of purchase. We searched MEDLINE and PreMEDLINE, 
Econlit, CINAHL, Embase, PsycINFO, Scopus, and the Cochrane 
Central Register of Controlled Trials for articles published in 
English between Jan 1, 2007, and April 30, 2013, that used high 
quality research designs to test the use of incentives to influence 
behaviours related to physical activity. The search terms used 
were combinations of the keywords “behavioural economics”, 
“behavioural interventions”, “incentives”, “financial incentives”, 
and “non-communicable diseases”, “chronic diseases”, “physical 
activity”. 
Added value of this study
To our knowledge, this is the first large-scale, randomised 
controlled trial that tests the effectiveness of activity trackers in 
full-time workers, either alone or in combination with one of 
two incentive strategies (namely, cash and charitable donations) 
to increase physical activity and improve health outcomes. 
Economic theory suggests that incentives would extend the 
period that participants wear activity trackers and boost 
increases in activity as individuals strive to obtain the rewards. 
We tested these hypotheses, in total and separately, for 
insufficiently active and active participants during a 6 month 
period when incentives are in effect and during the subsequent 
6 months without the incentives to test for habit formation. 
Despite some evidence of the ability of the tracker to improve 
step activity, we identified no evidence of improvements in 
health outcomes, either with or without incentives.
Implications of all the available evidence
The preponderance of evidence suggests that activity trackers 
have little ability to improve health outcomes related to 
inactivity. Our findings suggest that coupling the tracker with 
incentives might hold some promise, but that if the incentives 
are provided in cash they would probably need to be in place 
long term to avoid an undermining effect resulting from their 
removal. Future research should investigate alternate incentive 
strategies that provide a stronger link between the target of the 
incentives and health outcomes, such as incentivisation of 
bouts of moderate-to-vigorous physical activity.
consistent with the theory of reasoned action, which states 
that people will perform a behaviour if they evaluate it 
positively and believe it important that others think they 
should perform it.10 Charitable incentives might also be 
preferred by employers in view of the positive public 
relations and tax deductions for donating to charity.
The goal of this randomised controlled trial (trial of 
economic incentives to promote physical activity 
[TRIPPA]) is to test the extent to which an activity tracker, 
with or without modest incentives paid either in cash or 
via charitable donations, can increase physical activity 
and improve health outcomes among working people 
during a 6 month period, and to quantify the extent to 
which any improvements are sustained during the 
subsequent 6 months after incentives are removed 
(termed habit formation). We hypothesised that the 
activity tracker would have a slight positive effect on 
physical activity and health outcomes compared with the 
control group (no tracker or incentives) at 6 months, but 
that greater effectiveness would result from the incentives, 
with cash incentives hypothesised to have the largest 
effects. The value of cash and charity incentives would be 
strengthened if results showed evidence of habit 
formation. Although not expressly prespecified in the 
study protocol, we tested these hypotheses in total and 
separately for active and insufficiently active participants. 
This is an important stratification because providing 
incentives for participants who are already active might 
not be viewed as a good use of resources by funders.
Methods
Study design and participants
TRIPPA was a four-arm, 6 month randomised controlled 
trial with a 6 month post-intervention follow-up period, 
done in 13 organisations spanning many industries and 
sectors of government, to investigate the effect of an 
activity tracker, with or without cash or charitable 
incentives, on physical activity and health outcomes 
among full-time workers in Singapore. Although these 
organisations spanned diverse industries, most 
employees at these organisations held desk jobs that 
provided little opportunity for work-related physical 
activity. The study design has been described in detail 
elsewhere.9 Despite being a highly walkable city, 42% of 
full-time workers surveyed from Singapore’s general 
population were insufficiently active based on self-
reported physical activity.12
To be eligible, participants had to be English speaking 
(English is one of four official languages of Singapore), 
full-time workers, aged 21–65 years, willing to be randomly 
allocated to one of the four study groups, willing to wear an 
activity tracker for the duration of the study, able to walk 
at least ten steps continuously, and non-pregnant. 
Organisations were engaged through existing contacts and 
“cold calls”. If companies responded positively, a study 
briefing was done to apprise the management of study 
details. Once we received confirmation of participation 
from the management team, recruitment materials 
(eg, electronic direct mails, posters, and newsletters) 
communicating information about the study were 
disseminated to employees through internal channels 
unique to each organisation. Participants who answered 
yes to any of the questions on the Physical Activity 
Readiness Questionnaire,13 or had a BMI of more than 
40 kg/m² were required to obtain physician consent before 
enrolment. To dissuade marginally interested participants 
from joining, participants were required to pay an 
enrolment fee of S$10·00 (US$1=S$1·34) upon giving 
informed consent by signing the consent form. We had 
originally proposed to collect a refundable deposit of 
S$20·00 for the Fitbit Zip in addition to the enrolment 
fee at enrolment; participants subsequently randomly 
assigned to the control group would have been immediately 
refunded the S$20·00. However, this requirement was 
waived before the start of recruitment after consultations 
with worksite representatives revealed that a total fee of 
S$30·00 might be prohibitive for some employees.
The study protocol (appendix) was approved by the 
institutional review board at the National University 
of Singapore.
Randomisation and masking
We randomly assigned participants to one of four study 
groups: control (no tracker or incentives), activity tracker 
and website (Fitbit), tracker plus charitable incentives 
(charity), and tracker plus cash incentives (cash). Although 
randomisation was done at the individual level, we allowed 
exercise companions to sign up in groups of up to four 
members and be randomly allocated to the same study 
group. Randomisation of groups of a particular size was 
done in blocks of size four to ensure approximate balance 
between study groups for participants of each group size. 
We randomly assigned groups (with 1–4 members) to one 
of the four study groups in a 1:1:1:1 ratio, using a computer 
generated assignment schedule prepared by the 
statistician. Randomisation envelopes containing a slip of 
paper indicating the study group were prepared by 
research staff not involved in random allocation. The 
envelopes were arranged in sequential order for each 
stratum (ie, groups of 1–4 members), and the top-most 
envelope was picked by the study coordinator on the basis 
of the stratum to which the participant belonged. Because 
of the nature of the intervention, the participants and 
study coordinator could not be blinded to the study group 
assignment. However, team members involved in 
assessing outcomes in participants and data analysts were 
blinded to group assignment.
Procedures
Upon enrolment, all participants received educational 
booklets, published by the Singapore Health Promotion 
Board, entitled Active for Life14 and Brisk Walk Your Way 
to Better Health.15 These booklets give readers a better 
understanding of the benefits of and strategies for 
See Online for appendix
increasing physical activity. Participants in the Fitbit, 
charity, and cash groups also received the Fitbit Zip 
wireless activity tracker (Fitbit, San Francisco, CA) and 
access to the Fitbit website, which provides feedback on 
daily step activity and additional features (eg, badges, 
competitions) aimed to sustain increased activity levels. 
Fitbit Zip is a small, waist-worn pedometer with high 
validity and reliability.16 We instructed participants to 
wear the Fitbit in the same position every day. We told 
participants in the two incentive groups that they could 
earn weekly incentives: S$15 if they logged between 
50 000 and 70 000 steps per week or S$30 if they logged 
70 000 or more steps per week.
To prevent injuries, a maximum of 20 000 steps per day 
were counted. The key difference between the incentive 
groups was that the cash group participants received the 
incentives for themselves, whereas the charity group 
participants raised money for a charity of their choice 
from a list of 13 local charities representing causes ranging 
from child welfare to wildlife conservation. Participants in 
the cash and charity groups also had access to the TRIPPA 
website where they could track incentives earned.
To keep the other participants engaged in the study, 
control and Fitbit participants earned a weekly participation 
payment of S$4, irrespective of number of steps recorded. 
We distributed these payments, and the incentive 
payments, at the participants’ worksites every 4–6 weeks. 
Donations to charities were made via an online portal. 
Before receiving incentive payments, we asked participants 
in the charity and cash groups to sign an oath affirming 
that they (or their designated charity) were being paid for 
their own physical activity. Research reveals that such 
oaths reduce the likelihood of participants engaging in 
dishonest behaviour.11
All physical activity outcomes, including steps, were 
measured for participants in all groups via sealed 
accelerometers (ActiGraph triaxial GT-3x+ accelerometer 
[ActiGraph, Pensacola, FL, USA]) at baseline, 6 months, 
and 12 months. We instructed participants to wear the 
accelerometer for at least 10 waking hours on each day for 
7 consecutive days during each assessment interval. We 
quantified mean counts per min measured by the 
accelerometer by dividing the sum of total counts by the 
number of min per day of wear time across all adherent 
days (defined as ≥10 h/day of wear). We processed 
accelerometer data in R (version 3.1.2; R Core Team, 
Vienna, Austria) using the accelerometry package for 
triaxial accelerometers to obtain standard variables based 
on vector magnitude counts.17 We defined moderate-to-
vigorous physical activity (MVPA) as a vector magnitude of 
2690 counts per min or higher.18 We defined MVPA bout 
min as a total of 10 or more consecutive min at the vector 
magnitude cutoff points, with allowance for interruptions 
of 1–2 min at a magnitude less than the cutoff point.19
To measure health outcomes, we recorded participants’ 
height (Seca 217 Mobile Stadiometer, Seca Deutschland, 
Hamburg, Germany), weight (Seca 869 Mobile Floor 
Scale, Seca GmBH, Hamburg, Germany), blood pressure, 
and heart rate (Welch-Allyn Spot Vital Signs BP monitor, 
Welch Allyn, NY, USA) at baseline. We recorded the same 
measurements, with the exception of height, during the 
follow-up assessments at 6 months and 12 months.
To encourage participants to attend follow-up 
assessments, we gave participants in all four groups a 
S$25 supermarket voucher and a one in ten chance of 
receiving a S$50 voucher for completing the month 6 
assessment, and a S$35 voucher and one in ten chance of 
receiving a S$50 voucher for completing the month 12 
assessment.
Outcomes
We defined the primary outcome as MVPA bout min per 
week measured via accelerometry, assessed at 6 months 
(when the intervention ended) and at 12 months (post-
intervention follow-up period). We focused on weekly 
MVPA bout min as our primary outcome because steps 
during MVPA bouts are more likely than less vigorous 
activity to affect health outcomes. However, because 
incentives were tied to meeting weekly step goals, we 
included mean daily steps and percentage of participants 
who met the 70 000 weekly step goal as key secondary 
outcomes. The health outcomes we measured included 
weight, systolic blood pressure, cardiorespiratory fitness 
(maximum oxygen consumption [VO2max]; measured by a 
non-exercise testing of cardiorespiratory fitness [NET-F]),20 
and quality of life (measured by the EuroQoL EQ-5D-5L 
questionnaire).21 We converted the EQ-5D-5L responses to 
quality-of-life weights using the Thailand EQ-5D-5L 
crosswalk value sets.22 Other secondary outcomes assessed 
were weekly steps, sedentary or light physical activity min 
per week, moderate physical activity min per week, 
vigorous physical activity min per week, equivalence of 
moderate physical activity min per week, participants 
meeting physical activity guideline of 150 or more 
equivalence of moderate physical activity min per week, 
and participants meeting physical activity guideline of 
10 000 or more steps per day. The results for these 
secondary outcomes are included in the appendix. Because 
of the low risks involved, the institutional review board did 
not require collection and reporting of adverse events.
Statistical analysis
The study is powered to detect a difference of at least 
30 MVPA bout min per week between groups because 
increases less than this magnitude are unlikely to 
generate meaningful health improvements.23 On the 
basis of our pilot data (unpublished), this increase 
translates into a relative effect size of 0·35 SD difference 
in mean MVPA bout min per week between groups.24 
Assuming 20% attrition at month 12 and an intraclass 
correlation coefficient of 0·075, which is consistent with 
intraclass correlation coefficients for similar worksite-
based behavioural health interventions,25 we estimated 
that we would require 80 clusters of mean cluster size 
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2·5 per group. Mean cluster sizes of less than 2·5 would 
result in greater power. This translates to 200 participants 
per group, bringing the total sample size for recruitment 
to 800.
Analyses were done on an intention-to-treat basis and 
outcomes were assessed both for the whole study 
population and for active and insufficiently active 
respondents separately. Participants were classified as 
active or insufficiently active on the basis of their 
response to the NET-F at baseline. Those who self-
reported no physical activity or MVPA up to the 60 min 
per week category were classified as insufficiently active. 
Those who reported performing at or above the 1–3 h of 
MVPA per week category were classified as active.
203 assigned to Fitbit only group
202 received allocated intervention
1 did not receive allocated 
 intervention
 1 decided to participate in 
separate weight loss study
17 lost to follow-up




186 reached 6 month follow-up
26 lost to follow-up





161 reached 12 month follow-up
203 included in intention-to-treat analysis
199 assigned to charity group
194 received allocated intervention
5 did not receive allocated 
 intervention
4 declined to participate after 
 group allocation
1 became pregnant
21 lost to follow-up






            malfunction
178 reached 6 month follow-up
31 lost to follow-up







169 reached 12 month follow-up
199 included in intention-to-treat analysis
201 assigned to control group
12 lost to follow-up





          malfunction
189 reached 6 month follow-up
24 lost to follow-up




            malfunction
166 reached 12 month follow-up
201 included in intention-to-treat analysis
197 assigned to cash incentive group
197 received allocated intervention  
7 lost to follow-up
    4 dropped out or 
        uncontactable
    1 became pregnant
    1 relocated overseas
    1 accelerometer 
       malfunction
190 reached 6 month follow-up
22 lost to follow-up





161 reached 12 month follow-up
297 included in intention-to-treat analysis
1307 participants assessed for eligibility
507 excluded
192 did not meet inclusion criteria
4 not aged 21–65 years
33 not full-time employees
81 unwilling to be randomly assigned
42 unwilling to wear pedometer
20 unable to walk up to ten steps at a time
10 pregnant
2 had less than 2 valid days of accelerometer data
315 unavailable or could not be contacted
800 randomly assigned
2 did not complete 6 month 
follow-up
4 did not complete 6 month 
follow-up
1 did not complete 6 month 
follow-up
Figure 1: Trial profile
All statistical analyses were based on estimates pooled26 
across 20 multiple imputed datasets27 with each complete 
dataset based on 50 iterations of predictive mean matching 
imputation of each dependent variable’s missing values 
conditional on all other variables. Each of the 20 complete 
datasets was formed by looping across variables for 
50 iterations. Within each iteration, each variable’s non-
missing values were regressed on all other variables via 
stepwise variable selection using the Akaike information 
criterion, then noisy predictions for the variable’s missing 
Control (n=201) Fitbit (n=203) Charity (n=199) Cash (n=197)
Age (years) 35·6 (8·6) 35·4 (8·3) 35·5 (8·6) 35·5 (8·4)
Sex
Male 89 (44%) 103 (51%) 94 (47%) 84 (43%)
Female 112 (56%) 100 (49%) 105 (53%) 113 (57%)
Ethnicity
Chinese 138 (69%) 133 (66%) 145 (73%) 132 (67%)
Malay 10 (5%) 13 (6%) 5 (3%) 8 (4%)
Indian 30 (15%) 26 (13%) 17 (9%) 32 (16%)
Other 19 (9%) 26 (13%) 27 (14%) 24 (12%)
Not declared 4 (2%) 5 (2%) 5 (3%) 1 (1%)
Education
High school or lower 12 (6%) 9 (4%) 7 (4%) 11 (6%)
Some college 31 (15%) 27 (13%) 21 (11%) 28 (14%)
College graduate 98 (49%) 100 (49%) 100 (50%) 80 (41%)
Postgraduate 56 (28%) 58 (29%) 60 (30%) 73 (37%)
Other 0 3 (1%) 6 (3%) 4 (2%)
Not declared 4 (2%) 6 (3%) 5 (3%) 1 (1%)
Monthly personal income
<$5000 103 (51%) 93 (46%) 92 (46%) 92 (47%)
$5000–$9999 41 (20%) 46 (23%) 43 (22%) 37 (19%)
≥$10 000 12 (6%) 15 (7%) 8 (4%) 15 (8%)
Prefer not to say 40 (20%) 43 (21%) 50 (25%) 52 (26%)
Don’t know 1 (<1%) 1 (<1%) 1 (1%) 0
Not declared 4 (2%) 5 (2%) 5 (3%) 1 (1%)
Monthly household income
<$5000 52 (26%) 49 (24%) 49 (25%) 53 (27%)
$5000–$9999 56 (28%) 57 (28%) 49 (25%) 41 (21%)
≥$10 000 26 (13%) 29 (14%) 30 (15%) 30 (15%)
Prefer not to say 46 (23%) 49 (24%) 53 (27%) 58 (29%)
Don’t know 17 (8%) 14 (7%) 12 (6%) 14 (7%)
Not declared 4 (2%) 5 (2%) 5 (3%) 1 (1%)
Housing
Private 141 (70%) 157 (77%) 144 (72%) 144 (73%)
Public 54 (27%) 40 (20%) 48 (24%) 48 (24%)
Other 2 (1%) 1 (<1%) 2 (1%) 4 (2%)
Not declared 4 (2%) 5 (2%) 5 (3%) 1 (1%)
Participants who were insufficiently active at 
baseline*
129 (68%; 61–75) 121 (63%; 56–70) 125 (66%; 58–72) 123 (63%; 56–70)
MVPA bout min per week
Full sample 121 (105–137) 131 (114–148) 114 (100–127) 131 (115–148)
Insufficiently active 98 (82–115) 99 (79–119) 101 (85–117) 108 (88–127)
Active 159 (128–190) 182 (150–214) 141 (117–166) 174 (145–204)
Daily steps
Full sample 8030 (7680–8380) 8000 (7670–8330) 7780 (7460–8090) 8300 (7950–8650)
Insufficiently active 7620 (7270–7970) 7550 (7160–7940) 7530 (7150–7900) 7770 (7370–8170)
Active 8670 (7910–9420) 8660 (8040–9270) 8280 (7690–8870) 9240 (8600–9880)
(Table 1 continues on next page)
components were generated from the regression model, 
and matched to their nearest non-missing entry.
Point estimates along with clustered standard errors 
within each multiple imputed dataset were based on 
generalised linear mixed-effects models with random 
effects for worksite, group, and, if the outcome was a 
repeated measure, individual participant. We adjusted 
comparisons across study groups at each assessment for 
baseline outcome value, age, sex, race, and for accelerometer 
wear time-adjusted estimates, baseline 6 month and 
12 month wear time. All estimates are produced at the 
mean value of the independent variables, including mean 
wear time for the wear time-adjusted estimates.
At month 6, we noticed a significantly higher wear time 
effect for those in the cash group compared with the other 
groups (appendix). This effect probably occurred because 
participants wore the accelerometer and Fitbit together 
and increased their wear time or physical activity, or both, 
relative to baseline in an effort to meet the reward 
threshold. We present results unadjusted for 
accelerometer wear time as our primary analysis. 
Although not expressly stated in the study protocol, we 
also included results adjusted for wear time in the 
appendix because we cannot disentangle the competing 
hypotheses of increased wear time or physical activity, or 
both. We did the statistical analyses in R (version 3.1.0).
This study is registered with ClinicalTrials.gov, 
number NCT01855776.
Role of the funding source
The funder of the study had no role in study design, data 
collection, data analysis, data interpretation, or writing of 
the report. The corresponding author had full access to 
all the data in the study and had final responsibility for 
the decision to submit for publication.
Results
Between June 13, 2013, and Aug 15, 2014, we recruited 
800 full-time employees from 15 worksites. 
201 participants were randomly assigned to control, 
203 to the Fitbit group, 199 to the charity group, and 
197 to the cash group (figure 1). Even though participants 
were allowed to enrol in groups of up to four people, 
771 (96%) participants enrolled as singletons. The mean 
age of participants was 35 years and 370 (46%) were men. 
Consistent with Singapore’s population demographics, 
most participants were of Chinese ethnic origin (n=548 
[69%]), followed by Indian ethnic origin (n=105 [13%]), 
and Malay ethnic origin (n=36 [5%]). Most of the 
participants (n=625 [78%]) were college graduates or 
postgraduates and 48% had monthly personal incomes 
of less than S$5000 (table 1). At baseline 498 (62%) of all 
participants were insufficiently active and 270 (34%) were 
active; 454 (57%) were overweight or obese, and 69 (9%) 
were hypertensive (table 1).
After 6 months, 57 (7%) participants were lost to follow-
up; 12 in the control group, 17 in the Fitbit group, 21 in the 
charity group, and seven in the cash group (figure 1). After 
12 months, 153 (19%) participants were lost to follow-up; 34 
in the control group, 43 in the Fitbit group, 48 in the charity 
group, and 28 in the cash group. Logistic regressions 
revealed that sex and ethnic origin were the only 
sociodemographic predictors of participants being lost to 
follow-up at month 12. Women participants had 1·8 
(95% CI 1·2–2·8) times greater odds of dropping out 
compared with men, and the odds of dropping out were 
3·1 (1·9–5·3) times greater in participants of Indian ethnic 
origin and 1·8 (1·1–3·2) times greater in participants of 
other ethnic origin compared with participants of Chinese 
ethnic origin (appendix). All participants were included in 
the analyses for all primary and secondary outcomes.
Control (n=201) Fitbit (n=203) Charity (n=199) Cash (n=197)
(Continued from previous page)
Participants meeting ≥70 000 steps per week
Full sample 31 (17%; 12–23) 37 (21%; 15–27) 25 (14%; 9–19) 37 (20%; 15–27)
Insufficiently active 16 (12%; 7–19) 17 (15%; 9–23) 15 (12%; 7–19) 15 (14%; 8–21)
Active 15 (28%; 17–41) 20 (28%; 18–40) 10 (15%; 8–26) 22 (32%; 22–45)
Weight (kg) 66·4 (64·4–68·3) 66·9 (64·8–69·0) 66·5 (64·6–68·4) 64·5 (62·6–66·4)
Overweight or obese participants 114 (57%; 50–64) 114 (56%; 49–63) 121 (61%; 54–68) 105 (53%; 46–60)
Systolic blood pressure (mm Hg) 116 (113–118) 114 (111–116) 115 (112–117) 115 (113–118)
Patients with hypertension 19 (9%; 5–14) 13 (6%; 3–10) 17 (9%; 5–13) 20 (10%; 6–14)
NET-F VO2max (mL/kg per min) 35·0 (34·3–35·6) 35·7 (35·0–36·3) 35·3 (34·7–36·0) 35·4 (34·8–36·1)
EQ-5D-5L quality-of-life score 0·89 (0·88–0·91) 0·89 (0·87–0·91) 0·88 (0·86–0·90) 0·89 (0·87–0·91)
Data are mean (SD), n (%), mean (95% CI), and n (%; 95% CI). Dollars are S$. This table has been partly reproduced from reference 9. All baseline levels of outcomes are reported 
before multiple imputation. Participants who reported performing up to 60 min of MVPA per week were classified as insufficiently active. Participants who reported performing 
at or above the 1–3 h of MVPA per week category were classified as active. Insufficiently active and active participants are subsets of the total sample. Participants with BMI 
≥23 kg/m² are categorised as overweight. Participants with systolic blood pressure of ≥140 mm Hg or a diastolic blood pressure of ≥90 mm Hg, or both, are classified as 
hypertensive. VO2max is the maximum rate of oxygen consumption as measured during exercise and reflects the physical fitness of an individual. EQ-5D-5L is a standardised means 
of measuring generic health status. MVPA=moderate-to-vigorous physical activity. NET-F=non-exercise testing for cardiorespiratory fitness. VO2max=maximum oxygen 
consumption. *Participants were classified as insufficiently active or active on the basis of their response to the NET-F.
Table 1: Baseline characteristics and levels of primary and secondary outcome measures by study group
Compared with the Fitbit group, participants in the cash 
and charity groups who wore the Fitbit logged more daily 
steps during each week of the intervention (figure 2). The 
mean daily step count among wearers was 11 010 steps in 
the cash group, 9280 in the charity group, and 8550 in the 
Fitbit group. Even after 1 week, dropout rates were greater 
in the Fitbit and charity groups (figure 2). By 6 months, 
only 249 (62%) of 402 participants in the Fitbit or charity 
groups were wearing the device, whereas 174 (88%) of 
197 participants in the cash group were still wearing the 
device. However, when incentives were no longer offered, 
non-wear increased substantially in the cash group; by 
month 12, only a mean of about 10% of participants in all 
three groups were still wearing the device.
Between baseline and month 6, participants in the 
control group showed a reduction in mean daily steps and 
Figure 2: Mean number of daily steps and percentage of Fitbit Zip wear, by study group
Percentage of Fitbit wear indicates the percentage of participants who wore the Fitbit for at least 1 day in that week. Any day during which a participant logged 500 or 
more steps on the Fitbit was regarded as a valid day and constituted wearing the tracker for that day. The control group is not included in these graphs because control 
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MVPA bout min per week (table 2). By contrast, charity 
and Fitbit participants showed stable step and MVPA bout 
min per week during this time period. Only participants in 
the cash group showed increases in physical activity from 
baseline: mean daily steps increased by 570 steps (95% CI 
210–930; p=0·0016) and were statistically greater for both 
active and insufficiently active participants. Cash 
participants were also 8% (95% CI 0–17; p=0·0458) more 
likely at month 6 to meet the 70 000 weekly step target as 
compared with baseline. However, step increases only 
translated into a significant increase (22 min [95% CI 
5–38; p=0·0096]) in MVPA bout min per week for 
participants who were insufficiently active at baseline.
The charity group was no more effective at increasing 
MVPA bout min per week than the Fitbit group at the 
conclusion of the incentive period at 6 months (table 2). 
Both groups seemed to experience less deterioration in 
physical activity compared with control, but the results 
were only significant for the charity group. After 
controlling for baseline differences, charity participants 
engaged in an additional 21 MVPA bout min per week 
(95% CI 2–39; p=0·0310) compared with control. No 
significant difference in MVPA bout min per week was 
found between the Fitbit and control groups.
Even after controlling for baseline differences, both 
insufficiently active and active participants in the cash 
group showed increases in mean daily steps compared 
with participants in the other groups at the conclusion of 
the incentive period at 6 months (table 2). However, for 
MVPA bout min per week, only the differences from 
control were significant (table 2). For the full sample, cash 
participants logged an additional 29 MVPA bout min per 
week (95% CI 10–47; p=0·0024) compared with control at 
the 6 month assessment point: 24 MVPA bout min per 
week (3–46; p=0·0254) more for those who were 
insufficiently active at baseline and 37 MVPA bout 
min per week (2–71; p=0·0473) more for those who were 
active.
Results adjusted for accelerometer wear time 
(appendix) were similar to the results before this 
adjustment, although the magnitude of the differences 
and significance were attenuated between the cash and 
the other groups. During the 6 month incentive period, 
participants in the charity group earned S$320·00 for 
charity on average, with 36% of the total earnings for 
charity going to participants who were already active at 
baseline. The participants in the cash group earned 
S$620·00 on average, with 62% of the cash earned by 
those who were already active at baseline.
At 12 months, 6 months after the incentives concluded, 
physical activity among control participants remained 
below baseline, with results amplified for MVPA bout 
Difference from baseline, by study group Between-group comparisons








Cash vs Fitbit Cash vs charity
MVPA bout min per week
Full sample –16 (–29 to 
–3; p=0·0228)
0 (–13 to 
13; p=0·9626)
5 (–9 to 
18; p=0·5068)
13 (–1 to 
26; p=0·0643)
16 (–2 to 
35; p=0·0854)
21 (2 to 39; 
p=0·0310)
5 (–13 to 
23; p=0·6492)
29 (10 to 
47; p=0·0024)
13 (–6 to 
31; p=0·1800)




–3 (–19 to 
13; p=0·7136)
7 (–9 to 
23; p=0·3707)
10 (–6 to 
26; p=0·2847)
22 (5 to 38; 
p=0·0096)
10 (–12 to 
32; p=0·3439)
12 (–9 to 
34; p=0·2758)
2 (–19 to 
24; p=0·8937)
24 (3 to 
46; 
p=0·0254)
14 (–8 to 
36; p=0·2024)
12 (–10 to 
34; p=0·2561)
Active –39 (–65 to
–14; p=0·0033)
–13 (–37 to 
11; p=0·3048)
–4 (–29 to 
21; p=0·7806)
–3 (–27 to 
21; p=0·8186)
27 (–8 to 
62; p=0·1513)
36 (0 to 71; 
p=0·0572)
9 (–26 to 
43; p=0·6148)
37 (2 to 
71; p=0·0473)
10 (–24 to 44; 
p=0·5738)
1 (–34 to 
36; p=0·9650)
Mean daily steps
Full sample –480 (–830 to 
–120; 
p=0·0099)
–130 (–490 to 
230; 
p=0·4495)
–300 (–660 to 
70; 
p=0·1138)
570 (210 to 
930; 
p=0·0016)
340 (–100 to 
790; 
p=0·1362)
180 (–270 to 
630; 
p=0·4319)
–160 (–610 to 
280; 
p=0·4943)
1050 (600 to 
1490; 
p<0·0001)
700 (260 to 
1150; 
p=0·0015)





–180 (–600 to 
240; 
p=0·4071)
–130 (–550 to 
290; 
p=0·4721)
–180 (–600 to 
250; 
p=0·3863)
460 (40 to 
890; 
p=0·0336)
50 (–470 to 
570; 
p=0·9267)
0 (–510 to 
520; 
p=0·9780)
–50 (–560 to 
470; 
p=0·9063)
640 (120 to 
1160; 
p=0·0152)
590 (70 to 
1110; 
p=0·0218)
640 (110 to 
1170; 
p=0·0145)
Active –960 (–1610 to 
–310; 
p=0·0037)
–130 (–7450 to 
490; 
p=0·7524)
–510 (–1160 to 
140; 
p=0·1496)
700 (80 to 
1320; 
p=0·0227)
830 (–10 to 
1670; 
p=0·0431)






1660 (820 to 
2500; 
p=0·0001)
830 (10 to 
1650; 
p=0·0505)
1210 (380 to 
2050; 
p=0·0052)
Participants meeting ≥70 000 steps per week target
Full sample –6% (–11 to 
–1; p=0·0216)
–1% (–7 to 5;
p=0·7028)
3% (–4 to 9; 
p=0·3836)
8% (0 to 17; 
p=0·0458)
4% (–4 to  
12; p=0·1460)
8% (0 to 17; 
p=0·0238)
4% (–5 to 
13; p=0·3700)
14% (4 to  
24; p=0·0025)
10% (–1 to  
20; p=0·0985)




–2% (–9 to 4; 
p=0·4555)
1% (–7 to 
9; p=0·9133)
0% (–7 to 7; 
p=0·9168)
8% (–2 to 
17; p=0·1111)
3% (–7 to 
13; p=0·5387)
2% (–8 to 12; 
p=0·6464)
–1% (–12 to 
10; p=0·8804)
10% (–2 to 
22; p=0·1022)
7% (–6 to 
19; p=0·2940)
8% (–4 to 20; 
p=0·2402)
Active –10% (–19 to 
–1; p=0·0088)
–4% (–15 to 
7; p=0·4921)
9% (–5 to 
23; p=0·1559)
10% (–6 to 
25; p=0·1997)
6% (–8 to 
21; p=0·1176)
19% (3 to 36; 
p=0·0047)
13% (–5 to 
31; p=0·1332)
20% (2 to 
38; p=0·0048)
14% (–5 to 
33; p=0·1703)
1% (–20 to 
21; p=0·7743)
Data are change in accelerometer-derived endpoints (95% CI; p value). Test of endpoints at month 6 were adjusted for baseline endpoint value, age, sex, and ethnic origin. MVPA=moderate-to-vigorous 
physical activity.
Table 2: Change in steps and MVPA bouts at month 6 (unadjusted for wear time)
min per week due to a larger reduction from baseline 
among active participants whose MVPA bout min per 
week reduced by 51 min (95% CI –82 to –20; p=0·0012) 
from baseline (table 3). Fitbit and charity participants 
showed similar step counts at months 6 and 12. However, 
MVPA bout min per week were significantly greater 
than baseline for the full sample among Fitbit 
participants (16 min [95% CI 2 to 30; p=0·0301]) and for 
the insufficiently active subset of charity participants 
(17 min [2 to 32; p=0·0231]). Cash participants showed 
MVPA bouts and steps similar to baseline.
We identified no evidence that provision of charity 
incentives produced higher MVPA bout min per week 
than provision of Fitbit only at the 12 month follow-up 
(table 3). Although the effects on steps in the active and 
insufficiently active participants in the Fitbit and charity 
groups at month 12 are similar to those at month 6 
compared with control, largely because of the continued 
reduction in MVPA bout min per week in participants in 
the control group, the between-group comparison 
estimates of MVPA bout min per week are significantly 
greater in these groups compared with control, with 
overall differences exceeding 30 MVPA bout min per 
week in both groups. By contrast, although at month 12 
the cash group still had a significantly higher number of 
average daily steps and a higher likelihood of meeting the 
weekly step target than the control group, the increase in 
MVPA bout min per week was no longer significant. 
Moreover, the cash group did not have a higher number of 
average daily steps or a greater likelihood of reaching the 
weekly step target than the Fitbit or charity groups. In fact, 
we noted a potential undermining effect of cash incentives 
on MVPA bout min when comparing the cash group with 
the Fitbit group, driven by a net difference of 42 MVPA 
bout min per week (95% CI –79 to –5; p=0·0246) among 
participants who were already active at baseline.
None of the activity changes yielded significant 
improvements in health outcomes (such as BMI, systolic 
blood pressure, VO2max, or EQ-5D-5L index) at either 
month 6 or month 12 (table 4). Results for all other 
secondary outcomes are shown in the appendix. Few 
secondary outcomes showed significant differences.
Discussion
Wearable activity trackers are becoming increasingly 
popular. However, our results show that they are unlikely 
to be a panacea for rising rates of chronic disease. Although 
the trackers seem to have been effective at stemming a 
reduction in physical activity seen in participants in the 
control group at 12 months, we identified no evidence of 
improved health outcomes. The reason for this result 
might be because the Fitbit group participants did not 
Difference from baseline by, study group Between-group comparisons 
Control 
(n=201)
Fitbit (n=203) Charity 
(n=199)








Cash vs Fitbit Cash vs charity
MVPA bout min per week 
Full sample –22 (–36 to –7; 
p=0·0032)
16 (2 to 30; 
p=0·0301)
10 (–4 to 24; 
p=0·1751)
–7 (–21 to 7; 
p=0·3403)
37 (19 to 56; 
p=0·0001)
32 (12 to 51; 
p=0·0013)
–6 (–25 to 14; 
p=0·5607)
15 (–5 to 34; 
p=0·1363)
–23 (–42 to 
–4; p=0·0184)




–8 (–23 to 7; 
p=0·2967)
16 (0 to 32; 
p=0·0547)
17 (2 to 32; 
p=0·0231)
2 (–13 to 18; 
p=0·7891)
24 (2 to 46; 
p=0·0353)
25 (4 to 46; 
p=0·0179)
2 (–20 to 24; 
p=0·8802)
10 (–12 to 32; 
p=0·3679)
–14 (–36 to 9; 
p=0·2298)
–15 (–37 to 6; 
p=0·1663)
Active –51 (–82 to 
–20; p=0·0012)
17 (–12 to 46; 
p=0·2575)
–1 (–32 to 
29; p=0·9146)





49 (11 to 88; 
p=0·0127)
–18 (–56 to 20; 
p=0·3403)
26 (–13 to 
64; 
p=0·1890)
–42 (–79 to 
–5; p=0·0246)
–24 (–61 to 14; 
p=0·2160)
Mean daily steps
Full sample –480 (–880 to 
–80; 
p=0·0198)
–30 (–420 to 
370; 
p=0·8950)
–70 (–480 to 
330; 
p=0·7161)
30 (–370 to 
430; 
p=0·8853)
450 (–10 to 
910; 
p=0·0561)
400 (–60 to 
860; 
p=0·0856)
–50 (–510 to 
420; 
p=0·8398)
500 (50 to 
960; 
p=0·0289)
60 (–400 to 
510; 
p=0·8100)





–180 (–610 to 
260;
p=0·4257)
0 (–450 to 
460; 
p=0·9876)
160 (–280 to 
600; 
p=0·4886)
40 (–400 to 
480; 
p=0·8626)
180 (–370 to 
730; 
p=0·5213)
330 (–190 to 
850; 
p=0·2118)
150 (–400 to 
700; 
p=0·5883)
220 (–310 to 
740; 
p=0·4237)
40 (–530 to 
600; 
p=0·9016)
–120 (–640 to 
410; 
p=0·6658)
Active –1020 (–1730 
to –310; 
p=0·0048)






–60 (–740 to 
620; 
p=0·8658)
980 (120 to 
1840; 
p=0·0256)
610 (–270 to 
1480; 
p=0·1746)
–370 (–1220 to 
470; 
p=0·3875)
960 (90 to 
1840; 
p=0·0305)
–20 (–860 to 
830; 
p=0·9702)
360 (–480 to 
1190; 
p=0·4009)
Participants meeting ≥70 000 steps per week target
Full sample –6% (–11 to 
–1; p=0·0172)
–1% (–8 to 5; 
p=0·7658)
4% (–4 to 11; 
p=0·3129)
4% (–4 to 12; 
p=0·3611)
5% (–3 to 14; 
p=0·1031)
10% (1 to 19; 
p=0·0195)
5% (–6 to 15; 
p=0·3534)
10% (0 to 19; 
p=0·0149)
5% (–6 to 15; 
p=0·3913)




–3% (–9 to 3; 
p=0·3743)
0% (–8 to 8; 
p=0·9817)
1% (–7 to 8; 
p=0·8960)
5% (–5 to 15; 
p=0·2809)
3% (–7 to 13; 
p=0·5069)
3% (–7 to 13; 
p=0·4709)
0% (–11 to 11; 
p=0·9384)
8% (–4 to 
20; p=0·1608)
5% (–8 to 18; 
p=0·4567)
5% (–8 to 17; 
p=0·5094)
Active –11% (–21 to –1; 
p=0·0128)
–3% (–16 to 9;
p=0·6315)
11% (–5 to 26; 
p=0·1591)
1% (–13 to 15; 
p=0·8848)
8% (–8 to 24; 
p=0·0873)
22% (3 to 41; 
p=0·0075)
14% (–6 to 34; 
p=0·1741)
12% (–5 to 
29; p=0·0339)
4% (–14 to 22; 
p=0·6481)
–10% (–30 to 
11; p=0·3218)
Data are change in accelerometer-derived endpoints (95% CI; p value). Test of endpoints at month 12 were adjusted for baseline endpoint value, age, sex, and ethnic origin. MVPA=moderate-to-vigorous 
physical activity.
Table 3: Change in steps and MVPA bouts at month 12 (unadjusted for wear time)
show an increase in steps, and the increase in MVPA bout 
min relative to baseline was only 16 min per week on 
average, which is probably not enough to generate 
noticeable improvements in any health outcomes.
In this study, even among a selected group of employees 
who volunteered to participate, 40% abandoned the Fitbit 
within 6 months, and 90% did so by month 12. Because 
there seemed to be some beneficial effects in participants 
in the Fitbit group at month 12 despite the lack of wear, it 
is possible that participants wore the unit for a brief 
period of time, learned about their activity patterns, and 
then stopped wearing the device. This knowledge might 
have allowed these participants to stem the reduction in 
physical activity that was seen in the control group, 
despite the lack of continued wear.
Although participants in the charity group earned a 
mean of S$320·00 for charity, most likely by increasing 
the amount of time they wore the device, this strategy 
does not seem to be a good use of resources with respect 
to the employee’s physical activity. Results, in terms of 
physical activity and health outcomes with the charity 
incentive, were no better than just providing the 
participant with a Fitbit device.
The results for the cash group are not so straightforward. 
Cash incentives clearly affected participant behaviour. 
Unlike the other groups, during the incentive period, 
cash motivated both insufficiently active and active 
participants to increase physical activity levels. These 
results are consistent with findings from three other 
randomised controlled trials28–30 that tested the use of 
incentives to influence physical activity, albeit using 
incentive schemes very different from that used in the 
present study. As with our study, two of the three studies 
showed significant increases in activity, although none 
was longer than 16 weeks in duration.
Despite the step effect, the net effect of the cash incentive 
on MVPA bouts was small, averaging just more than an 
additional 4 min per day. Consequently, the fact that the 
step increases did not translate into noticeable increases 
in health outcomes is not surprising. Despite this small 
effect on activity, the mean earnings of participants in the 
cash group was S$620·00. This cash incentive is a 
substantial expense and one that most third-party payers 
would be unlikely to undertake without evidence of 
improvements in health outcomes, especially considering 
that once the incentives were removed activity levels 
trended back to baseline values.
The absence of improvements in health outcomes in 
the cash group might be related to how the cash incentive 
was implemented. We chose to focus participants on 
Difference from baseline, by study group Between-group comparisons
Control 
(n=201)
Fitbit (n=203) Charity 
(n=199)
Cash (n=197) Fitbit vs control Charity vs 
control
Charity vs Fitbit Cash vs control Cash vs Fitbit Cash vs charity
Changes at month 6
Weight (kg) –0·3 (–1·0 to 
0·4; 
p=0·3725)
0·2 (–0·6 to 
0·9; 
p=0·7959)
0·1 (–0·6 to 
0·9; 
p=0·8031)
0·4 (–0·3 to 
1·1; 
p=0·3122)
0·49 (–0·54 to 
1·53; 
p=0·4185)
0·45 (–0·59 to 
1·49; 
p=0·4224)
–0·05 (–1·11 to 
1·01; 
p=0·9950)
0·71 (–0·31 to 
1·73; 
p=0·1805)
0·22 (–0·81 to 
1·25; 
p=0·6063)






2·5 (–0·8 to 
5·9; 
p=0·1620)
–1·3 (–4·7 to 
2·1; 
p=0·4838)
–0·5 (–4·0 to 
3·0; 
p=0·7851)






–2·97 (–7·41 to 
1·46; 
p=0·1833)
0·83 (–3·59 to 
5·25; 
p=0·7423)
–2·85 (–7·05 to 
1·35; 
p=0·1684)
0·95 (–3·28 to 
5·18; 
p=0·7587)





0·4 (–0·1 to 
0·8; 
p=0·0809)
0·7 (0·3 to 
1·1; 
p=0·0002)
0·5 (0·0 to 
0·9; 
p=0·0107)
0·9 (0·5 to 
1·3; 
p<0·0001)
0·35 (–0·21 to 
0·92;
 p=0·1452)
0·10 (–0·50 to 
0·69; 
p=0·5502)
–0·26 (–0·82 to 
0·31; 
p=0·4138)
0·51 (–0·06 to 
1·08; 
p=0·0778)
0·16 (–0·40 to 
0·71; 
p=0·7523)





–2·1 (–4·0 to 
–0·1; 
p=0·0515)
–1·8 (–3·8 to 
0·2; 
p=0·0863)
–2·1 (–4·1 to 
–0·1; 
p=0·0601)
–0·5 (–2·5 to 
1·4; 
p=0·5731)
0·26 (–2·45 to 
2·96; 
p=0·8517)
–0·03 (–2·72 to 
2·65; 
p=0·9385)
–0·29 (–3·05 to 
2·48; 
p=0·9144)
1·52 (–1·14 to 
4·17; 
p=0·2861)
1·26 (–1·42 to 
3·95; 
p=0·3844)
1·55 (–1·16 to 
4·26; 
p=0·3273)
Changes at month 12
Weight (kg) –1·3 (–2·8 to 
0·2; 
p=0·0957)
–0·4 (–2·1 to 
1·2; 
p=0·5882)
–0·8 (–2·4 to 
0·7; 
p=0·2777)
–0·6 (–2·1 to 
1·0; 
p=0·4575)
0·9 (–1·2 to 
3·0; p=0·4188)
0·5 (–1·5 to 
2·4; p=0·6429)




–0·1 (–2·2 to 
1·9; p=0·8908)








–0·2 (–4·1 to 
3·7; 
p=0·9319)






0·1 (–4·9 to 
5·1; p=0·9666)
2·5 (–2·3 to 
7·3; p=0·3118)
2·4 (–2·7 to 
7·4; p=0·3586)
–0·6 (–5·5 to 
4·3; p=0·8057)
–0·7 (–5·8 to 
4·4; p=0·7823)







1·6 (0·6 to 
2·6; p=0·0017)
1·3 (0·4 to 
2·2; 
p=0·0061)
1·7 (0·7 to 
2·6; 
p=0·0008)
0·2 (–0·8 to 
1·2; p=0·7453)
–0·1 (–1·1 to 
0·9; p=0·7767)
–0·3 (–1·3 to 
0·7; p=0·5508)
0·2 (–0·8 to 
1·2; p=0·6578)
0·1 (–1·0 to 
1·1; p=0·9090)




–1·7 (–3·7 to 
0·3; 
p=0·0898)
–1·3 (–3·3 to 
0·6; 
p=0·1848)






0·4 (–2·2 to 
3·0; p=0·7614)
–0·1 (–2·7 to 
2·5; p=0·9626)
–0·5 (–3·2 to 
2·2; p=0·7362)
1·6 (–1·0 to 
4·3; p=0·2237)
1·2 (–1·5 to 
4·0; p=0·3696)
1·7 (–0·9 to 
4·3; p=0·2022)
Data are change in health outcomes (95% CI; p value). Comparisons across study groups of secondary outcomes at months 6 and 12 were adjusted for baseline outcome value, age, sex, and ethnic origin. 
NET-F=non-exercise testing for cardiorespiratory fitness. VO2max=maximum oxygen consumption.
Table 4: Changes in health outcomes at months 6 and 12
meeting weekly step targets and used somewhat arbitrary 
targets and reward amounts. The strategy used in this 
study is one among a myriad of potential strategies. 
Although it is possible that our study was too short to 
show improvements in the chosen health indicators or 
that the population was too healthy at baseline for the 
intervention to produce a significant difference, the 
absence of an improvement in health outcomes might be 
due to the small increase in MVPA bouts min in 
participants assigned to the cash group. On average, cash 
incentive participants increased their weekly steps by 
7336, or a distance of roughly 5·9 km, between baseline 
and month 6. However, this increase in steps translated 
into only a small increase of 4 min per day in MVPA 
bouts. The rewards might have been better spent had they 
targeted MVPA min or MVPA steps (sometimes called 
active or aerobic steps) directly, which many activity 
trackers also report. However, in view of the absence of 
increases in activity or improvements in health outcomes 
at month 12, any incentive strategy would probably need 
to be sustained over a longer period of time for health 
improvements to be seen.
This study has several limitations. Because the sample 
comprised full-time employees from selected worksites 
who volunteered to participate, our participants were 
probably healthier and more motivated to be physically 
active than the average full-time worker. The reduction in 
physical activity reported in control participants might be 
because their baseline physical activity was artificially 
high as a result of joining the study or wearing the 
accelerometer for the first time. For these reasons, our 
results might not have external validity. Another issue is 
that of potential contamination because participants 
within worksites but in different study groups might 
have interacted with each other. Although we would have 
preferred to randomise at the worksite level, we were 
unable to convince employers to participate in a study 
where some worksites might have been randomly 
assigned to the control group. Consequently, our results 
might be conservative because contamination would bias 
the results towards the null hypothesis.
In summary, our results provide some evidence of the 
ability of the tracker to improve step activity. However, we 
find no evidence of improvements in health outcomes, 
either with or without incentives. Since cash incentives 
were shown to increase weekly steps, other incentive 
strategies that provide a stronger link between the target 
of the incentives and health outcomes, such as 
incentivising MVPA bout min directly, might yield 
greater effectiveness. However, results suggest any cash 
incentive strategy would probably need to be in place 
long term to avoid any potential undermining effect 
resulting from their removal.
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